A new NIAID study suggests the TNA assay could be used in humans. Read more about this study.
You can help researchers improve public health by volunteering for NIAID clinical studies related to biodefense and emerging infectious diseases.
NIAID conducts and supports basic research to better understand viruses, bacteria, and other infectious agents that cause diseases of public health concern. This research provides the foundation for developing medical products and strategies to diagnose, treat and prevent a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism.
Learn more about NIAID’s Role in Biodefense and Emerging Infectious Diseases Research.
Chikungunya Vaccine Trial Begins Enrollment—Dec. 20, 2011
Antibody Treatment Protects Monkeys from Hendra Virus Disease—Oct. 19, 2011
NIH Funds Development of New Broad-Spectrum Therapeutics—Oct. 13, 2011
Experimental Vaccine Protects Monkeys from Blinding Trachoma—Oct. 7, 2011
All Biodefense and Emerging Infectious Diseases News and Events
News from NIAID-Supported Institutions
Last Updated February 01, 2012